IDE (rs6583817) polymorphism and pulse pressure are independently and interactively associated with level and change in executive function in older adults

Psychology and Aging

Volumn 29, Issue 2, 2014, Pages 418-430

  Peggy McFall, G ^a   Wiebe, Sandra A ^a   Vergote, David ^b   Jhamandas, Jack ^a   Westaway, David ^b   Dixon, Roger A ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Executive functions; Gene health analyses; Insulin degrading enzyme; Pulse pressure; Victoria longitudinal study

Indexed keywords

INSULINASE;

ADULT; AGED; AGING; ALLELE; ARTICLE; COGNITION; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HEALTH STATUS; HOMOZYGOTE; HUMAN; LONGITUDINAL STUDY; MALE; NORMAL HUMAN; OUTCOME ASSESSMENT; PATH ANALYSIS; PHENOTYPE; PULSE PRESSURE; RISK FACTOR; TASK PERFORMANCE; BLOOD PRESSURE; CANADA; COGNITIVE DEFECT; FACTORIAL ANALYSIS; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; ALLELES; BLOOD PRESSURE; BRITISH COLUMBIA; COGNITION; COGNITION DISORDERS; EXECUTIVE FUNCTION; FACTOR ANALYSIS, STATISTICAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INSULYSIN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 84903148481     PISSN: 08827974     EISSN: 19391498     Source Type: Journal    
DOI: 10.1037/a0034656     Document Type: Article

References (81)

1. Andrés, P.,&Van der Linden, M. (2000). Age-related differences in supervisory attentional system functions. Journal of Gerontology, Series B: Psychological Sciences and Social Sciences, 55, 373-380.
2. Anstey, K.,&Christensen, H. (2000). Education, activity, health, blood pressure, and apolipoprotein E as predictors of cognitive change in old age: A review. Gerontology, 46, 163-177.
3. Awad, N., Gagnon, M.,&Messier, C. (2004). The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. Journal of Clinical and Experimental Neuropsychology, 26, 1044-1080.
4. Bartl, J., Scholz, C.-J., Hinterberger, M., Jungwirth, S., Wichart, I., Rainer, M. K., . . . Grunblatt, E. (2011). Disorder-specific effects of polymorphisms at opposing ends of the insulin degrading enzyme gene. BioMed Central Medical Genetics, 12. Accessed at www.biomedcentral.com/1471-2350/12/151.
5. Belbin, O., Crump, M., Bisceglio, G. D., Carrasquillo, M. M., Morgan, K., & Younkin, S. G. (2011). Multiple insulin degrading enzyme variants alter in vitro reporter gene expression. PLoS ONE, 6, e21429.
6. Belsky, J., Jonassaint, C., Pluess, M., Stanton, M., Brummett, B., & Williams, R. (2009). Vulnerability genes or plasticity genes? Molecular Psychiatry, 14, 746-754.
7. Bennett, R. G., Duckworth, W. C.,&Hamel, F. G. (2000). Degradation of amylin by insulin-degrading enzyme. The Journal of Biological Chemistry, 275, 36621-36625.
8. Berg, E. A. (1948). A simple objective technique for measuring flexibility in thinking. Journal of General Psychology, 39, 15-22.
9. Bielak, A. A. M., Mansueti, L., Strauss, E.,&Dixon, R. A. (2006). Performance on the Hayling and Brixton tests in older adults: Norms and correlates. Archives of Clinical Neuropsychology, 21, 141-149.
10. Biessels, G. J., Deary, I. J.,&Ryan, C. M. (2008). Cognition and diabetes: A lifespan perspective. Lancet Neurology, 7, 184-190.
11. Blomqvist, M. E.-L., Chalmers, K., Andreasen, N., Bogdanovic, N., Wilcock, G. K., Cairns, N. J., . . . Prince, J. A. (2005). Sequence variants of IDE are associated with the extent of ß-amyloid deposition in the Alzheimer's disease brain. Neurobiology of Aging, 26, 795-802.
12. Brainerd, C. J., Reyna, V. F., Petersen, R. C., Smith, G. E.,&Taub, E. S. (2011). Is the Apolipoprotein E genotype a biomarker for mild cognitive impairment? Findings from a nationally representative study. Neuropsychology, 25, 679-689.
13. Burgess, P. W.,&Shallice, T. (1997). The Hayling and Brixton tests. Thurston, Suffolk, England: Thames Valley Test Company.
14. Carrasquillo, M. M., Belbin, O., Zou, F., Allen, M., Ertekin-Taner, N., Ansari, M., . . . Morgan, K. (2010). Concordant association of insulin degrading enzyme gene (IDE) variants with IDE mRNA, Aß, and Alzheimer's disease. PLoS ONE, 5, e8764.
15. Colcombe, S. J., Erickson, K. I., Raz, N., Webb, A. G., Cohen, N. J., McAuley, E.,&Kramer, A. F. (2003). Aerobic fitness reduces brain tissue loss in aging humans. Journal of Gerontology: Medical Sciences, 58A, 176-180.
16. Craft, S.,&Watson, G. S. (2004). Insulin and neurodegenerative disease: Shared and specific mechanisms. The Lancet Neurology, 3, 169-178.
17. Dahle, C. L., Jacobs, B. S.,&Raz, N. (2009). Aging, vascular risk, and cognition: Blood glucose, pulse pressure, and cognitive performance in healthy adults. Psychology and Aging, 24, 154-162.
18. Dart, A. M.,&Kingwell, B. A. (2001). Pulse pressure - a review of mechanisms and clinical relevance. Journal of the American College of Cardiology, 37, 975-984.
19. Davenport, M. H., Hogan, D. B., Eskes, G. A., Longman, R. S.,&Poulin, M. J. (2012). Cerebrovascular reserve: The link between fitness and cognitive function? Exercise and Sports Science Reviews, 40, 153-158.
20. Deary, I. J., Wright, A. F., Harris, S. E., Whalley, L. J.,&Starr, J. M. (2004). Searching for genetic influences on normal cognitive aging. Trends in Cognitive Sciences, 8, 178-184.
21. de Frias, C. M., Dixon, R. A.,&Strauss, E. (2006). Structure of four executive functioning tests in healthy older adults. Neuropsychology, 20, 206-214.
22. de Frias, C. M., Dixon, R. A.,&Strauss, E. (2009). Characterizing executive functioning in older special populations: From cognitively elite to cognitively impaired. Neuropsychology, 23, 778-791.
23. D'Elia, L. F., Satz, P., Uchiyama, C. L.,&White, T. (1996). Color Trails Test: Professional manual. Odessa, FL: Psychological Assessment Resources.
24. Dixon, R. A. (2011). Enduring theoretical themes in psychological aging: Derivation, functions, perspectives, and opportunities. In K. W. Schaie & S. L. Willis (Eds.), Handbook of the psychology of aging (7th ed., pp. 3-23). San Diego, CA: Academic Press.
25. Dixon, R. A.,&de Frias, C. M. (2004). The Victoria Longitudinal Study: From characterizing cognitive aging to illustrating changes in memory compensation. Aging, Neuropsychology, and Cognition, 11, 346-376.
26. Dixon, R. A., Small, B. J., MacDonald, S. W. S.,&McArdle, J. J. (2012). Yes, memory declines with aging - but when, how, and why? In M. Naveh-Benjamin&N. Ohta (Eds.), Memory and aging (pp. 325-347). New York, NY: Psychology Press.
27. Elias, P. K., Elias, M. F., Robbins, M. A.,&Budge, M. M. (2004). Blood pressure-related cognitive decline: Does age make a difference? Hypertension, 44, 631-636.
28. Enders, C. K. (2011). Analyzing longitudinal data with missing values. Rehabilitation Psychology, 56, 267-288.
29. Folstein, M. F., Folstein, S. E.,&McHugh, P. R. (1975). "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
30. Fotuhi, M., Hachinski, V.,&Whitehouse, P. J. (2009). Changing perspectives regarding late-life dementia. Nature Reviews Neurology, 5, 649-658.
31. Franklin, S., Gustin, W., Wong, N., Larson, M., Weber, M., Kannel, W., & Levy, D. (1997). Hemodynamic patterns of age-related changes in blood pressure - The Framingham Heart Study. Circulation, 96, 308-315.
32. Graham, J. W., Olchowski, A. E.,&Gilreath, T. D. (2007). How many imputations are really needed? Some practical clarifications of multiple imputation theory. Prevention Science, 8, 206-213.
33. Grober, E., Hall, C. B., Lipton, R. B., Zonderman, A. B., Resnick, S. M., & Kawas, C. (2008). Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease. Journal of the International Neuropsychological Society, 14, 266-278.
34. Haan, M. N., Shemanski, L., Jagust, W. J., Manolio, T. A.,&Kuller, L. (1999). The role of APOEe4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA: Journal of the American Medical Association, 282, 40-46.
35. Hagen, K., Pettersen, E., Stovner, L. J., Skorpen, F., Holmen, J.,&Zwart, J.-A. (2007). High systolic blood pressure is associated with val/val genotype in the catechol-O-methyltransferase gene. American Journal of Hypertension, 20, 21-26.
36. Harris, S. E.,&Deary, I. J. (2011). The genetics of cognitive ability and cognitive aging in healthy older people. Trends in Cognitive Sciences, 15, 388-394.
37. Hertzog, C. (2008). Theoretical approaches to the study of cognitive aging: An individual-differences perspective. In S. M. Hofer&D. F. Alwin (Eds.), Handbook of cognitive aging: Interdisciplinary perspectives (pp. 34-49). Thousand Oaks, CA: SAGE.
38. Kline, R. B. (2011). Principles and practice of structural equation modeling (3rd ed.). New York, NY: Guilford Press.
39. Kremen, W. S.,&Lyons, M. J. (2011). Behavior genetics of aging. In K. W. Schaie&S. L. Willis (Eds.), Handbook of the psychology of aging (7th ed., pp. 93-107). San Diego, CA: Academic Press.
40. Kurochkin, I. V.,&Goto, S. (1994). Alzheimer's ß-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. Federation of European Biochemical Societies Letters, 345, 33-37.
41. Lindenberger, U., Nagel, I. E., Chicherio, C., Li, S.-C., Keekeren, H. R., & Bäckman, L. (2008). Age-related decline in brain resources modulates genetic effects on cognitive functioning. Frontiers in Neuroscience, 2, 234-244.
42. Luszcz, M. (2011). Executive function and cognitive aging. In K. W. Schaie&S. L. Willis (Eds.), The handbook of the psychology of aging (7th ed., pp. 59-72). San Diego, CA: Academic Press.
43. Mahley, R. W.,&Rall, S. C., Jr. (2000). Apolipoprotein E: Far more than a lipid transport protein. Annual Review of Genomics and Human Genetics, 1, 507-537.
44. Mattace-Raso, F. U., van der Cammen, T. J., Hofman, A., van Popele, N. M., Bos, M. L., Schalekamp, M. A., . . . Wotteman, J. C. (2006). Arterial stiffness and risk of coronary heart disease and stroke: The Rotterdam Study. Circulation, 113, 657-663.
45. McFall, G. P., Wiebe, S. A., Vergote, D., Westaway, D., Jhamandas, J., & Dixon, R. A. (2013). IDE (rs6583817) polymorphism and type 2 diabetes differentially modify executive function in older adults. Neurobiology of Aging, 34, 2208-2216.
46. Mitchell, G. F., Vasan, R. S., Keyes, M. J., Parise, H., Wang, T. J., Larson, M. G., . . . Benjamin, E. J. (2007). Pulse pressure and risk of new-onset atrial fibrillation. Journal of the American Medical Association, 297, 709-715.
47. Miyake, A., Friedman, N. P., Emerson, M. J., Witzki, A. H.,&Howerter, A. (2000). The unity and diversity of executive functions and their contributions to complex "frontal lobe" tasks: A latent variable analysis. Cognitive Psychology, 41, 49-100.
48. Muthén, L. K.,&Muthén, B. O. (2010). Mplus user's guide (6th ed.). Los Angeles, CA: Muthén&Muthén.
49. Nagel, I. E., Chicherio, C., Li, S.-C., von Oertzen, T., Sander, T., Villringer, A., . . . Lindenberger, U. (2008). Human aging magnifies genetic effects on executive functioning and working memory. Frontiers in Human Neuroscience, 2, 1-8.
50. Nathan, J., Wilkinson, D., Stammers, S.,&Low, L. (2001). The role of tests of frontal executive function in the detection of mild dementia. International Journal of Geriatric Psychiatry, 16, 18-26.
51. Qiu, C., Winblad, B.,&Fratiglioni, L. (2005). The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurology, 4, 487-499.
52. Qiu, C., Winblad, B., Viitanen, M.,&Fratiglioni, L. (2003). Pulse pressure and risk of Alzheimer disease in persons aged 75 years and older: A community-based, longitudinal study. Stroke; a Journal of Cerebral Circulation, 34, 594-599.
53. Qiu, W. Q.,&Folstein, M. F. (2006). Insulin, insulin-degrading enzyme and amyloid-ß peptide in Alzehimer's disease: Review and hypothesis. Neurobiology of Aging, 27, 190-198.
54. Rapp, M. A.,&Reischies, F. M. (2005). Attention and executive control predict Alzheimer disease in late life: Results from the Berlin Aging Study (BASE). The American Journal of Geriatric Psychiatry, 13, 134-141.
55. Raz, N., Dahle, C. L., Rodrigue, K. M., Kennedy, K. M.,&Land, S. (2011). Effects of age, genes, and pulse pressure on executive functions in healthy adults. Neurobiology of Aging, 32, 1124-1137.
56. Raz, N., Rodrigue, K. M.,&Acker, J. D. (2003). Hypertension and the brain: Vulnerability of the prefrontal regions and executive functions. Behavioral Neuroscience, 117, 1169-1180.
57. Raz, N., Rodrigue, K. M., Kennedy, K. M.,&Land, S. (2009). Genetic and vascular modifiers of age-sensitive cognitive skills: Effects of COMT, BDNF, ApoE, and hypertension. Neuropsychology, 23, 105-116.
58. Reitan, R. M.,&Wolfson, D. (1992). Neuropsychological evaluation of older children. Tucson, AZ: Neuropsychology Press.
59. Rubin, D. B. (1987). Multiple imputations for nonresponse in surveys. Hoboken, NJ: Wiley.
60. Saxby, B. K., Harrington, F., McKeith, I. G., Wesnes, K.,&Ford, G. A. (2003). Effects of hypertension on attention, memory, and executive function in older adults. Health Psychology, 22, 587-591.
61. Schaie, K. W. (2013). Developmental influences on adult intelligence (2nd ed.). New York, NY: Oxford University Press.
62. Schiffrin, E. L. (2004). Vascular stiffening and arterial compliance. Implications for systolic blood pressure. American Journal of Hypertension, 17, 39S-48S.
63. Seaquist, E. R., Latteman, D. F.,&Dixon, R. A. (2012). Diabetes and the brain: American Diabetes Association Research Symposium. Diabetes, 61, 3056-3062.
64. Shen, Y., Joachimiak, A., Rosner, M. R.,&Tang, W.-J. (2006). Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism. Nature, 443, 870-874.
65. Singer, J. D.,&Willett, J. B. (2003). Applied longitudinal data analysis: Modeling change and event occurrence. New York, NY: Oxford University Press.
66. Small, B. J., Dixon, R. A.,&McArdle, J. J. (2011). Tracking cognitionhealth changes from 55 to 95 years of age. The Journal of Gerontology, Series B: Psychological Sciences and Social Sciences, 66B, i153-i161.
67. Small, B. J., Dixon, R. A., McArdle, J. J.,&Grimm, K. J. (2012). Do changes in lifestyle engagement moderate cognitive decline in normal aging? Evidence from the Victoria Longitudinal Study. Neuropsychology, 26, 144-155.
68. Smith, J. D. (2002). Apolipoproteins and aging: Emerging mechanisms. Ageing Research Reviews, 1, 345-365.
69. Song, X., Mitnitski, A.,&Rockwood, K. (2011). Nontraditional risk factors combine to predict Alzheimer disease and dementia. Neurology, 77, 227-234.
70. Staessen, J. A., Richart, T.,&Birkenhäger, W. H. (2007). Less atherosclerosis and lower blood pressure for a meaningful life perspective with more brain. Hypertension, 49, 389-400.
71. Sternäng, O., Wahlin, Å., Adolfsson, R., Sleegers, K., Van Broeckhoven, C.,&Nilsson, L.-G. (2009). APOE and lipid level synergy effects on declarative memory functioning in adulthood. European Psychologist, 14, 268-278.
72. Taylor, S. F., Kornblum, S., Lauber, E. J., Minoshima, S.,&Koeppe, R. A. (1997). Isolation of specific interference processing in the Stroop task: PET activation studies. NeuroImage, 6, 81-92.
73. Turner, G. R.,&Spreng, R. N. (2012). Executive functions and neurocognitive aging: Dissociable patterns of brain activity. Neurobiology of Aging, 33, 826.el-826.e13.
74. Umegaki, H. (2012). Neurodegeneration in diabetes mellitus. In H. I. Ahmad (Ed.), Neurodegenerative diseases (pp. 258-265). New York, NY: Landes Bioscience and Springer Science-Business Media.
75. Vasan, R. S., Larson, M. G., Leip, E. P., Evans, J. C., O'Donnell, C. J., Kannel, W. B.,&Levy, D. (2001). Impact of high-normal blood pressure on the risk of cardiovascular disease. New England Journal of Medicine, 345, 1291-1297.
76. Waldstein, S. R., Rice, S. C., Thayer, J. F., Najjar, S. S., Scuteri, A., & Zonderman, A. B. (2008). Pulse pressure and pulse wave velocity are related to cognitive decline in the Baltimore Longitudinal Study of Aging. Hypertension, 51, 99-104.
77. West, R. L. (1996). An application of prefrontal cortex function theory to cognitive aging. Psychological Bulletin, 120, 272-292.
78. Wiebe, S. A., Espy, K. A.,&Charak, D. (2008). Using confirmatory factor analysis to understand executive control in preschool children: I. latent structure. Developmental Psychology, 44, 575-587.
79. Wiebe, S. A., Sheffield, T., Nelson, J. M., Clark, C. A. C., Chevalier, N., & Espy, K. A. (2010). The structure of executive function in 3-year-olds. Journal of Experimental Child Psychology, 108, 436-452.
80. Wishart, H. A., Roth, R. M., Saykin, A. J., Rhodes, C. H., Tsongalis, G. J., Pattin, K. A., . . . McAllister, T. W. (2011). COMT Val158Met genotype and individual differences in executive function in healthy adults. Journal of the International Neuropsychological Society, 17, 174-180.
81. Yeung, S. E., Fischer, A. L.,&Dixon, R. A. (2009). Exploring effects of Type 2 diabetes on cognitive functioning in older adults. Neuropsychology, 23, 1-9.